Erin Weeda to Cardiovascular Agents
This is a "connection" page, showing publications Erin Weeda has written about Cardiovascular Agents.
Connection Strength
0.606
-
Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life. Int J Cardiol. 2018 Dec 15; 273:34-38.
Score: 0.576
-
A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction. J Clin Pharmacol. 2016 08; 56(8):936-47.
Score: 0.030